Inflammasomes have been reportedly activated by NLRP3-ASC-caspase-1, promoting the expression of the downstream factors IL-18 and IL-1β and playing an anti-tumor role in colon cancer (Song and Li, 2018). Here, NLRP3 is linked to malignant colon neoplasm.